Search | VHL Search Portal

1.

Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.

Lakhani, Nehal J; Chow, Laura Q M; Gainor, Justin F; LoRusso, Patricia; Lee, Keun-Wook; Chung, Hyun Cheol; Lee, Jeeyun; Bang, Yung-Jue; Hodi, Frank Stephen; Kim, Won Seog; Santana-Davila, Rafael; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Kuo, Tracy C; Wan, Hong I; Pons, Jaume; Randolph, Sophia S; Messersmith, Wells A.

Lancet Oncol ; 22(12): 1740-1751, 2021 12.

Article in English | MEDLINE | ID: mdl-34793719

2.

A Phase 1 study of gefitinib combined with durvalumab in EGFR TKI-naive patients with EGFR mutation-positive locally advanced/metastatic non-small-cell lung cancer.

Creelan, Benjamin C; Yeh, Tammie C; Kim, Sang-We; Nogami, Naoyuki; Kim, Dong-Wan; Chow, Laura Q M; Kanda, Shintaro; Taylor, Rosemary; Tang, Weifeng; Tang, Mei; Angell, Helen K; Roudier, Martine P; Marotti, Marcelo; Gibbons, Don L.

Br J Cancer ; 124(2): 383-390, 2021 01.

Article in English | MEDLINE | ID: mdl-33012782

3.

Phase 1 study of epacadostat in combination with atezolizumab for patients with previously treated advanced nonsmall cell lung cancer.

Hellmann, Matthew D; Gettinger, Scott; Chow, Laura Q M; Gordon, Michael; Awad, Mark M; Cha, Edward; Gong, Xiaohua; Zhou, Gongfu; Walker, Chris; Leopold, Lance; Heist, Rebecca S.

Int J Cancer ; 147(7): 1963-1969, 2020 10 01.

Article in English | MEDLINE | ID: mdl-32141617

4.

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.

Antonia, Scott J; Borghaei, Hossein; Ramalingam, Suresh S; Horn, Leora; De Castro Carpeño, Javier; Pluzanski, Adam; Burgio, Marco A; Garassino, Marina; Chow, Laura Q M; Gettinger, Scott; Crinò, Lucio; Planchard, David; Butts, Charles; Drilon, Alexander; Wojcik-Tomaszewska, Joanna; Otterson, Gregory A; Agrawal, Shruti; Li, Ang; Penrod, John R; Brahmer, Julie.

Lancet Oncol ; 20(10): 1395-1408, 2019 10.

Article in English | MEDLINE | ID: mdl-31422028

5.

Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial.

Guerriero, Margaret K; Redman, Mary W; Baker, Kelsey K; Martins, Renato G; Eaton, Keith; Chow, Laura Q; Santana-Davila, Rafael; Baik, Christina; Goulart, Bernardo H; Lee, Sylvia; Rodriguez, Cristina P.

Cancer ; 124(13): 2841-2849, 2018 07 01.

Article in English | MEDLINE | ID: mdl-29669181

6.

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012.

Mehra, Ranee; Seiwert, Tanguy Y; Gupta, Shilpa; Weiss, Jared; Gluck, Iris; Eder, Joseph P; Burtness, Barbara; Tahara, Makoto; Keam, Bhumsuk; Kang, Hyunseok; Muro, Kei; Geva, Ravit; Chung, Hyun Cheol; Lin, Chia-Chi; Aurora-Garg, Deepti; Ray, Archana; Pathiraja, Kumudu; Cheng, Jonathan; Chow, Laura Q M; Haddad, Robert.

Br J Cancer ; 119(2): 153-159, 2018 07.

Article in English | MEDLINE | ID: mdl-29955135

7.

Head and Neck Cancer. Reply.

Chow, Laura Q M.

N Engl J Med ; 382(20): e57, 2020 05 14.

Article in English | MEDLINE | ID: mdl-32402180

8.

Head and Neck Cancer.

Chow, Laura Q M.

N Engl J Med ; 382(1): 60-72, 2020 01 02.

Article in English | MEDLINE | ID: mdl-31893516

9.

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Borghaei, Hossein; Paz-Ares, Luis; Horn, Leora; Spigel, David R; Steins, Martin; Ready, Neal E; Chow, Laura Q; Vokes, Everett E; Felip, Enriqueta; Holgado, Esther; Barlesi, Fabrice; Kohlhäufl, Martin; Arrieta, Oscar; Burgio, Marco Angelo; Fayette, Jérôme; Lena, Hervé; Poddubskaya, Elena; Gerber, David E; Gettinger, Scott N; Rudin, Charles M; Rizvi, Naiyer; Crinò, Lucio; Blumenschein, George R; Antonia, Scott J; Dorange, Cécile; Harbison, Christopher T; Graf Finckenstein, Friedrich; Brahmer, Julie R.

N Engl J Med ; 373(17): 1627-39, 2015 Oct 22.

Article in English | MEDLINE | ID: mdl-26412456

10.

Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.

Plimack, Elizabeth R; Bellmunt, Joaquim; Gupta, Shilpa; Berger, Raanan; Chow, Laura Q M; Juco, Jonathan; Lunceford, Jared; Saraf, Sanatan; Perini, Rodolfo F; O'Donnell, Peter H.

Lancet Oncol ; 18(2): 212-220, 2017 Feb.

Article in English | MEDLINE | ID: mdl-28081914

11.

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.

Hellmann, Matthew D; Rizvi, Naiyer A; Goldman, Jonathan W; Gettinger, Scott N; Borghaei, Hossein; Brahmer, Julie R; Ready, Neal E; Gerber, David E; Chow, Laura Q; Juergens, Rosalyn A; Shepherd, Frances A; Laurie, Scott A; Geese, William J; Agrawal, Shruti; Young, Tina C; Li, Xuemei; Antonia, Scott J.

Lancet Oncol ; 18(1): 31-41, 2017 01.

Article in English | MEDLINE | ID: mdl-27932067

12.

Ceritinib in ALK-rearranged non-small-cell lung cancer.

Shaw, Alice T; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y; Goldwasser, Meredith; Boral, Anthony L; Engelman, Jeffrey A.

N Engl J Med ; 370(13): 1189-97, 2014 Mar 27.

Article in English | MEDLINE | ID: mdl-24670165

13.

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

Breitbach, Caroline J; Burke, James; Jonker, Derek; Stephenson, Joe; Haas, Andrew R; Chow, Laura Q M; Nieva, Jorge; Hwang, Tae-Ho; Moon, Anne; Patt, Richard; Pelusio, Adina; Le Boeuf, Fabrice; Burns, Joe; Evgin, Laura; De Silva, Naomi; Cvancic, Sara; Robertson, Terri; Je, Ji-Eun; Lee, Yeon-Sook; Parato, Kelley; Diallo, Jean-Simon; Fenster, Aaron; Daneshmand, Manijeh; Bell, John C; Kirn, David H.

Nature ; 477(7362): 99-102, 2011 Aug 31.

Article in English | MEDLINE | ID: mdl-21886163

14.

Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.

Seiwert, Tanguy Y; Burtness, Barbara; Mehra, Ranee; Weiss, Jared; Berger, Raanan; Eder, Joseph Paul; Heath, Karl; McClanahan, Terrill; Lunceford, Jared; Gause, Christine; Cheng, Jonathan D; Chow, Laura Q.

Lancet Oncol ; 17(7): 956-965, 2016 Jul.

Article in English | MEDLINE | ID: mdl-27247226

15.

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.

Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, Siyu; Szczudlo, Tomasz; Yovine, Alejandro; Shaw, Alice T.

Lancet Oncol ; 17(4): 452-463, 2016 Apr.

Article in English | MEDLINE | ID: mdl-26973324

16.

The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.

Pennock, Gregory K; Chow, Laura Q M.

Oncologist ; 20(7): 812-22, 2015 Jul.

Article in English | MEDLINE | ID: mdl-26069281

17.

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Brahmer, Julie R; Tykodi, Scott S; Chow, Laura Q M; Hwu, Wen-Jen; Topalian, Suzanne L; Hwu, Patrick; Drake, Charles G; Camacho, Luis H; Kauh, John; Odunsi, Kunle; Pitot, Henry C; Hamid, Omid; Bhatia, Shailender; Martins, Renato; Eaton, Keith; Chen, Shuming; Salay, Theresa M; Alaparthy, Suresh; Grosso, Joseph F; Korman, Alan J; Parker, Susan M; Agrawal, Shruti; Goldberg, Stacie M; Pardoll, Drew M; Gupta, Ashok; Wigginton, Jon M.

N Engl J Med ; 366(26): 2455-65, 2012 Jun 28.

Article in English | MEDLINE | ID: mdl-22658128

18.

Sunitinib combined with pemetrexed and carboplatin in patients with advanced solid malignancies--results of a phase I dose-escalation study.

Blais, Normand; Camidge, D Ross; Jonker, Derek J; Soulières, Denis; Laurie, Scott A; Diab, Sami G; Ruiz-Garcia, Ana; Thall, Aron; Zhang, Ke; Chao, Richard C; Chow, Laura Q.

Invest New Drugs ; 31(6): 1487-98, 2013 Dec.

Article in English | MEDLINE | ID: mdl-23963796

19.

Neutron radiotherapy for adenoid cystic carcinoma of the lacrimal gland.

Gensheimer, Michael F; Rainey, David; Douglas, James G; Liao, Jay J; Laramore, George E; Jian-Amadi, Arash; Chow, Laura Q M; Koh, Wui-Jin; Parvathaneni, Upendra.

Ophthalmic Plast Reconstr Surg ; 29(4): 256-60, 2013.

Article in English | MEDLINE | ID: mdl-23839633

20.

ACR Appropriateness Criteria® Staging and Post-Therapy Assessment of Head and Neck Cancer.

Gule-Monroe, Maria K; Calle, Susana; Policeni, Bruno; Juliano, Amy F; Agarwal, Mohit; Chow, Laura Q M; Dubey, Prachi; Friedman, Elliott R; Hagiwara, Mari; Hanrahan, Kate DuChene; Jain, Vikas; Rath, Tanya J; Smith, Russell B; Subramaniam, Rathan M; Taheri, M Reza; Yom, Sue S; Zander, David; Burns, Judah.

J Am Coll Radiol ; 20(11S): S521-S564, 2023 11.

Article in English | MEDLINE | ID: mdl-38040469

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: